Multicare Good Samaritan Home Health | |
3901 South Fife Street, Tacoma, Washington 98409 | |
(253) 301-6400 | |
Name | Multicare Good Samaritan Home Health |
---|---|
Location | 3901 South Fife Street, Tacoma, Washington |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 507046 |
Ownership Type | Voluntary Non-profit - Private |
Service Area Zip Codes | 98001, 98002, 98003, 98010, 98022, 98023, 98030, 98031, 98032, 98038, 98042, 98047, 98092, 98198, 98321, 98323, 98328, 98329, 98332, 98333, 98335, 98338, 98349, 98351, 98354, 98360, 98371, 98372, 98373, 98374, 98375, 98387, 98388, 98390, 98391, 98394, 98396, 98402, 98403, 98404, 98405, 98406, 98407, 98408, 98409, 98418, 98419, 98422, 98424, 98439, 98443, 98444, 98445, 98446, 98464, 98465, 98466, 98467, 98496, 98498, 98499, 98580 |
NPI Number | 1275647133 |
Organization Name | MULTICARE HEALTH SYSTEM |
Doing Business As | MULTICARE GOOD SAMARITAN HOME HEALTH |
Address | 3901 S Fife St, Tacoma, WA 98409 |
Phone Number | 253-301-6400 |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back.
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
› Verified 7 days ago
NPI Number | 1609868413 |
Organization Name | GOOD SAMARITAN HOSPITAL |
Doing Business As | MULTICARE GOOD SAMARITAN HOME HEALTH |
Address | 3901 S Fife St, Tacoma, WA 98409 |
Phone Number | 253-301-6400 |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back.
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
› Verified 7 days ago
Quality Rating: |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back.
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 96.4 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 97.5 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.2 | 99.6 |
How often the home health team checked patients for depression | 98.9 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 71.2 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 75.1 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.3 | 96.4 |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back.
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 73.5 | 79.6 |
How often patients got better at getting in and out of bed | 78.6 | 81.1 |
How often patients got better at bathing | 78.7 | 82.3 |
How often patients’ breathing improved | 72.8 | 82.8 |
How often patients’ wounds improved or healed after an operation | 87.8 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 66.6 | 75 |
How often home health patients had to be admitted to the hospital | 13.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15.2 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 87.6 | 94 |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back.
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back.
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
› Verified 7 days ago
The patient survey data of Multicare Good Samaritan Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 80 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 88 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 82 | 78 |
News Archive
Ohr Pharmaceutical, Inc., a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has enrolled the first 60 patients in the Company's ongoing OHR-002 Phase II clinical trial evaluating Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.
The National Cancer Institute has awarded a $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center to become the nation's sole operator of its Cancer Information Service Contact Center.
In October, we mourned those who died of breast cancer and celebrated all of the women (and men) who have survived. What many of those survivors worry about, though, is that their breast cancer may come back.
The German Research Foundation has established a new Collaborative Research Center on "Nanodimensional polymer therapeutics for tumor therapy" (CRC 1066) at Johannes Gutenberg University Mainz and the Max Planck Institute for Polymer Research (MPI-P).
› Verified 7 days ago
Kindred At Home Location: 4020 S 56th St, Ste 101, Tacoma, Washington 98409 Ratings: Phone: (253) 475-6862 | |
Multicare Good Samaritan Home Health Location: 3901 South Fife Street, Tacoma, Washington 98409 Ratings: Phone: (253) 301-6400 | |
Puget Sound Home Health Location: 3906 South 74th Street, Ste 101, Tacoma, Washington 98409 Ratings: Phone: (253) 581-9410 | |
Emerald Healthcare Inc Location: 4002 Tacoma Mall Blvd, Ste 204a, Tacoma, Washington 98409 Ratings: Phone: (253) 735-4282 | |
Envision Home Health Location: 1818 S Union Ave Ste 1a, Tacoma, Washington 98405 Ratings: Phone: (206) 452-0058 |